The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The cholinergic system and Parkinson disease
Open accessAbstract
Although Parkinson disease (PD) is viewed traditionally as a motor syndrome secondary to nigrostriatal dopaminergic denervation, recent studies emphasize non-motor features. Non-motor comorbidities, such as cognitive impairment, are likely the result of an intricate interplay of multi-system degenerations and neurotransmitter deficiencies extending beyond the loss of dopaminergic nigral neurons. The pathological hallmark of parkinsonian dementia is the presence of extra-nigral Lewy bodies that can be accompanied by other pathologies, such as senile plaques. Lewy first identified the eponymous Lewy body in neurons of the nucleus basalis of Meynert (nbM), the source of cholinergic innervation of the cerebral cortex. Although cholinergic denervation is recognized as a pathological hallmark of Alzheimer disease (AD), in vivo neuroimaging studies reveal loss of cerebral cholinergic markers in parkinsonian dementia similar to or more severe than in prototypical AD. Imaging studies agree with post-mortem evidence suggesting that basal forebrain cholinergic system degeneration appears early in PD and worsens coincident with the appearance of dementia. Early cholinergic denervation in PD without dementia appears to be heterogeneous and may make specific contributions to the PD clinical phenotype. Apart from well-known cognitive and behavioral deficits, central, in particular limbic, cholinergic denervation may be associated with progressive deficits of odor identification in PD. Recent evidence indicates also that subcortical cholinergic denervation, probably due to degeneration of brainstem pedunculopontine nucleus neurons, may relate to the presence of dopamine non-responsive gait and balance impairments, including falls, in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
STEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 849
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
The pedunculopontine nucleus and Parkinson's disease
Pahapill, P. A. (2000) · Brain · doi:10.1093/brain/123.9.1767 · Cited by 831
The organization and some projections of cholinergic neurons of the mammalian forebrain
Fibiger, H. C. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90011-x · Cited by 818
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686
Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain
Selden, N. (1998) · Brain · doi:10.1093/brain/121.12.2249 · Cited by 657
Mesholam, R. I., Moberg, P. J., Mahr, R. N., & Doty, R. L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.84 · Cited by 643
The parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
The epidemiology of dementia associated with Parkinson disease
Aarsland, D., & Kurz, M. W. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 578
Depression, intellectual impairment, and Parkinson disease
Mayeux, R., Stern, Y., Rosen, J., & Leventhal, J. (1981) · Neurology · doi:10.1212/wnl.31.6.645 · Cited by 572
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5976 · Cited by 554
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Self-citationBasal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Mesulam, M., & Geula, C. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902750205 · Cited by 518
Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
Davis, K. L. (1999) · JAMA · doi:10.1001/jama.281.15.1401 · Cited by 492
Presence of both odor identification and detection deficits in alzheimer's disease
Doty, R. L., Reyes, P. F., & Gregor, T. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90129-8 · Cited by 476
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Re-emergence of striatal cholinergic interneurons in movement disorders
Pisani, A., Bernardi, G., Ding, J., & Surmeier, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.008 · Cited by 466
Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases
Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., & Tomlinson, B. E. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90045-x · Cited by 459
Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., Villemagne, V. L., O'Keefe, G., Nagren, K., Chaudhury, K. R., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.127878 · Cited by 431
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
History of falls in Parkinson disease is associated with reduced cholinergic activity
Bohnen, N. I., Müller, M. L. T. M., Koeppe, R. A., Studenski, S. A., Kilbourn, M. A., Frey, K. A., & Albin, R. L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1ded6 · Cited by 409
Self-citationPrevalence of smell loss in Parkinson's disease – A multicenter study
Haehner, A., Boesveldt, S., Berendse, H. W., Mackay-Sim, A., Fleischmann, J., Silburn, P. A., Johnston, A. N., Mellick, G. D., Herting, B., Reichmann, H., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.12.005 · Cited by 403
The Cortical Dopamine System: Role in Memory and Cognition
(1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60846-7 · Cited by 394
Papp, M. I., & Lantos, P. L. (1994) · Brain · doi:10.1093/brain/117.2.235 · Cited by 389 · cited 1×
“The pathology of MSA is distinct from PD and consists of neuronal loss in the substantia nigra, striatum, cerebellum, brainstem and spinal cord with argyrophilic and glial inclusions [100].”
BackgroundThe pedunculopontine nucleus in Parkinson's disease
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., & Price, D. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260106 · Cited by 386
Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
Hilker, R., Thomas, A. V., Klein, J. C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A. H., Herholz, K., & Heiss, W. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191154.78131.f6 · Cited by 384
Jellinger, K. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.540 · Cited by 373
Lieberman, A., Dziatolowski, M., Kupersmith, M., Serby, M., Goodgold, A., Korein, J., & Goldstein, M. (1979) · Annals of Neurology · doi:10.1002/ana.410060409 · Cited by 370
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., Ota, T., Asahina, M., Fukushi, K., Kuwabara, S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b58 · Cited by 366
Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., Mathis, C. A., Davis, J. G., Moore, R. Y., & DeKosky, S. T. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0971-0 · Cited by 364
Self-citationThe pathogenesis of Parkinson's disease: a new hypothesis.
Barbeau, A. (1962) · PubMed · Cited by 344
Cholinergic-Anticholinergic Antagonism in Parkinsonism
Duvoisin, R. C. (1967) · Archives of Neurology · doi:10.1001/archneur.1967.00470260014002 · Cited by 342
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
Zaccai, J., McCracken, C., & Brayne, C. (2005) · Age and Ageing · doi:10.1093/ageing/afi190 · Cited by 340
Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi, P., Hansen, L. A., Alford, M., Sabbagh, M. N., Schoos, B., Masliah, E., Thal, L. J., & Corey-Bloom, J. (2000) · Neurology · doi:10.1212/wnl.54.2.407 · Cited by 328
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 320
Olfactory thresholds are associated with degree of dementia in Alzheimer's disease
MURPHY, C., GILMORE, M., SEERY, C., SALMON, D., & LASKER, B. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90014-q · Cited by 312
Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
Eglen, R. M. (2006) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8673.2006.00368.x · Cited by 311
The relationship between cerebral Alzheimer's disease pathology and odour identification in old age
Wilson, R. S., Arnold, S. E., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.099721 · Cited by 305
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303
Weihe, E., Tao-Cheng, J. H., Schäfer, M. K., Erickson, J. D., & Eiden, L. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3547 · Cited by 300
L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
Cools, R., Lewis, S. J. G., Clark, L., Barker, R. A., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301153 · Cited by 289
Lecourtier, L., & Kelly, P. H. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.01.004 · Cited by 283
Perry, E. K., & Perry, R. H. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1255 · Cited by 278
COOPER, J. A., SAGAR, H. J., DOHERTY, S. M., JORDAN, N., TIDSWELL, P., & SULLIVAN, E. V. (1992) · Brain · doi:10.1093/brain/115.6.1701 · Cited by 275
The nature and course of olfactory deficits in Alzheimer's disease
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.3.357 · Cited by 274
The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease
Marder, K., Tang, M.-X., Cote, L., Stern, Y., & Mayeux, R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310069018 · Cited by 268
Ruberg, M., Ploska, A., Javoy-Agid, F., & Agid, Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90615-1 · Cited by 263
Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E., & Bergman, H. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2083 · Cited by 261
Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
Nakano, I., & Hirano, A. (1984) · Annals of Neurology · doi:10.1002/ana.410150503 · Cited by 259
A 10‐item smell identification scale related to risk for Alzheimer's disease
Tabert, M. H., Liu, X., Doty, R. L., Serby, M., Zamora, D., Pelton, G. H., Marder, K., Albers, M. W., Stern, Y., & Devanand, D. P. (2005) · Annals of Neurology · doi:10.1002/ana.20533 · Cited by 248
Dementia in Parkinson disease: A neuropsychological analysis
Pirozzolo, F. J., Hansch, E. C., Mortimer, J. A., Webster, D. D., & Kuskowski, M. A. (1982) · Brain and Cognition · doi:10.1016/0278-2626(82)90007-0 · Cited by 238
Behaviorally contingent property of movement-related activity of the primate putamen
Kimura, M. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.63.6.1277 · Cited by 224
Perry, E. K., Irving, D., Kerwin, J. M., McKeith, I. G., Thompson, P., Collerton, D., Fairbairn, A. F., Ince, P. G., Morris, C. M., Cheng, A. V., et al. (1993) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199307020-00002 · Cited by 214
Lehéricy, S., Hirsch, É. C., Cervera‐Piérot, P., Hersh, L. B., Bakchine, S., Piette, F., Duyckaerts, C., Hauw, J., Javoy‐Agid, F., & Agid, Y. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903300103 · Cited by 207
Conroy, W. G., Vernallis, A. B., & Berg, D. K. (1992) · Neuron · doi:10.1016/0896-6273(92)90031-8 · Cited by 206
Regional distribution of muscarinic cholinergic receptors in rat brain
Kobayashi, R. M., Palkovits, M., Hruska, R. E., Rothschild, R., & Yamamura, H. I. (1978) · Brain Research · doi:10.1016/0006-8993(78)91047-8 · Cited by 206
Churchyard, A., & Lees, A. J. (1997) · Neurology · doi:10.1212/wnl.49.6.1570 · Cited by 205
Systematic Regional Variations in the Loss of Cortical Cholinergic Fibers in Alzheimer's Disease
Geula, C., & Mesulam, M.-M. (1996) · Cerebral Cortex · doi:10.1093/cercor/6.2.165 · Cited by 202 · cited 1×
“Losses are most severe in the temporal lobes, including the entorhinal cortex, where up to 80% of cholinergic axons are depleted [44].”
BackgroundCortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study
Geula, C., & Mesulam, M.-M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90399-0 · Cited by 202
Cognitive impairments in advanced PD without dementia
Green, J., McDonald, W. M., Vitek, J. L., Evatt, M., Freeman, A., Haber, M., Bakay, R. A. E., Triche, S., Sirockman, B., & DeLong, M. R. (2002) · Neurology · doi:10.1212/01.wnl.0000031426.21683.e2 · Cited by 202
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J. D., Brogan, D., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 200
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Atack, J. R., Perry, E. K., Bonham, J. R., Candy, J. M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02858.x · Cited by 194
Antidepressant studies in Parkinson's disease: A review and meta‐analysis
Weintraub, D., Morales, K. H., Moberg, P. J., Bilker, W. B., Balderston, C., Duda, J. E., Katz, I. R., & Stern, M. B. (2005) · Movement Disorders · doi:10.1002/mds.20555 · Cited by 191 · cited 1×
“A cholinergic component of PD depression may also explain the limited efficacy of serotonergic anti-depressant drugs in this disorder [133].”
BackgroundAn Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease
Mayeux, R., Stern, Y., Rosenstein, R., Marder, K., Hauser, A., Cote, L., & Fahn, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520270034017 · Cited by 190
Doty, R. L., Bromley, S. M., & Stern, M. B. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0011 · Cited by 187
Whitehouse, P. J., Martino, A. M., Wagster, M. V., Price, D. L., Mayeux, R., Atack, J. R., & Kellar, K. J. (1988) · Neurology · doi:10.1212/wnl.38.5.720 · Cited by 185
Tonically discharging neurons of monkey striatum respond to preparatory and rewarding stimuli
Apicella, P., Scarnati, E., & Schultz, W. (1991) · Experimental Brain Research · doi:10.1007/bf00230981 · Cited by 183
The pedunculopontine nucleus: its role in the genesis of movement disorders
Lee, M. S., Rinne, J. O., & Marsden, C. D. (2000) · Yonsei Medical Journal · doi:10.3349/ymj.2000.41.2.167 · Cited by 182
Cholinergic‐dependent cognitive deficits in Parkinson's disease
Dubois, B., Danzé, F., Pillon, B., Cusimano, G., Lhermitte, F., & Agid, Y. (1987) · Annals of Neurology · doi:10.1002/ana.410220108 · Cited by 178
Tiraboschi, P., Hansen, L. A., Alford, M., Merdes, A., Masliah, E., Thal, L. J., & Corey-Bloom, J. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.946 · Cited by 170
Mesulam, M. ‐., Mash, D., Hersh, L., Bothwell, M., & Geula, C. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903230209 · Cited by 169
Pimlott, S. L., Piggott, M., Owens, J., Greally, E., Court, J. A., Jaros, E., Perry, R. H., Perry, E. K., & Wyper, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300302 · Cited by 169
SAMUEL, W., ALFORD, M., HOFSTETTER, C. R., & HANSEN, L. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199705000-00006 · Cited by 167
Olfactory function in Parkinsonian syndromes
Müller, A., Müngersdorf, M., Reichmann, H., Strehle, G., & Hummel, T. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.1071 · Cited by 161
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes
Gilman, S., Koeppe, R. A., Nan, B., Wang, C.-N., Wang, X., Junck, L., Chervin, R. D., Consens, F., & Bhaumik, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a55 · Cited by 160
Neuropsychological Impairment in Parkinson's Disease With and Without Depression
Troster, A. I., Stalp, L. D., Paolo, A. M., Fields, J. A., & Koller, W. C. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360042014 · Cited by 158
Meyer, P. M., Strecker, K., Kendziorra, K., Becker, G., Hesse, S., Woelpl, D., Hensel, A., Patt, M., Sorger, D., Wegner, F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.106 · Cited by 158
Shute, C. C. D., & Lewis, P. R. (1966) · Cell and Tissue Research · doi:10.1007/bf00406286 · Cited by 152
Bohnen, N. I., Kaufer, D., Hendrickson, R., Constantine, G. M., Mathis, C. A., & Moore, R. Y. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100073 · Cited by 146
Self-citationZur pathologischen Anatomie der Paralysis agitans
Fünfgeld, E. W. (1923) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02869021 · Cited by 135
Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distribution
Heckers, S., Geula, C., & Mesulam, M. M. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903250107 · Cited by 134
Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease
Mattila, P. M., Röyttä, M., Torikka, H., Dickson, D. W., & Rinne, J. O. (1998) · Acta Neuropathologica · doi:10.1007/s004010050843 · Cited by 133
Mattila, P. M., Röyttä, M., Lönnberg, P., Marjamäki, P., Helenius, H. Y. M., & Rinne, J. O. (2001) · Acta Neuropathologica · doi:10.1007/s004010100372 · Cited by 131
Regional differences in the severity of Lewy body pathology across the olfactory cortex
Silveira‐Moriyama, L., Holton, J. L., Kingsbury, A. E., Ayling, H., Petrie, A., Sterlacci, W., Poewe, W. H., Maier, H., Lees, A. J., & Révész, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.006 · Cited by 130
The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease
Tiraboschi, P., Hansen, L. A., Alford, M. F., Masliah, E., Thal, L. J., & Corey‐Bloom, J. (2000) · Neurology · doi:10.1212/wnl.55.9.1278 · Cited by 130
Lange, K. W., Wells, F. R., Jenner, P. G., & MARSDEN, C. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05838.x · Cited by 126
A Network Representation of Response Probability in the Striatum
Blázquez, P. M., Fujii, N., Kojima, J., & Graybiel, A. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00627-x · Cited by 125
Cholinergic deficiency and frontal dysfunction in Parkinson's disease
Dubois, B., Pillon, B., Lhermitte, F., & Agid, Y. (1990) · Annals of Neurology · doi:10.1002/ana.410280202 · Cited by 125
Ruberg, M., Rieger, F., Villageois, A. P., Bonnet, A. M., & Agid, Y. (1986) · Brain Research · doi:10.1016/0006-8993(86)91401-0 · Cited by 121
Functional anatomy of human odor sensation, discrimination, and identification in health and aging.
Kareken, D. A., Mosnik, D. M., Doty, R. L., Džemidžić, M., & Hutchins, G. D. (2003) · Neuropsychology · doi:10.1037/0894-4105.17.3.482 · Cited by 120
Irie, T., Fukushi, K., Akimoto, Y., Tamagami, H., & Nozaki, T. (1994) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)90159-7 · Cited by 119
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.
Kuhl, D. E., Koeppe, R. A., Fessler, J. A., Minoshima, S., Ackermann, R. J., Carey, J. E., Gildersleeve, D. L., Frey, K. A., & Wieland, D. M. (1994) · PubMed · Cited by 117
Voluntary motor commands in human ballistic movements
Desmedt, J. E., & Godaux, E. (1979) · Annals of Neurology · doi:10.1002/ana.410050503 · Cited by 113
Kilbourn, M. R., Snyder, S. E., Sherman, P. S., & Kuhl, D. E. (1996) · Synapse · Cited by 107
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA
Gilman, S., Chervin, R. D., Koeppe, R. A., Consens, F. B., Little, R. J. A., An, H., Junck, L., & Heumann, M. (2003) · Neurology · doi:10.1212/01.wnl.0000073624.13436.32 · Cited by 103
Zur pathologischen Anatomie der Paralysis agitans
Naka, K. (1906) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02058003 · Cited by 101
Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease
Fujita, M., Ichise, M., Zoghbi, S. S., Liow, J., Ghose, S., Vines, D. C., Sangare, J., Lu, J., Cropley, V., Iida, H., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20688 · Cited by 100
Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 96
Mesulam, M. M., & Geula, C. (1992) · Brain Research · doi:10.1016/0006-8993(92)90543-i · Cited by 93
Dementia and Parkinson's Disease
Gibb, W. R. G. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.596 · Cited by 91
GAI, W. P., Halliday, G. M., Blumbergs, P. C., Geffen, L. B., & Blessing, W. W. (1991) · Brain · doi:10.1093/brain/114.5.2253 · Cited by 89
Mash, D. C., White, W. F., & Mesulam, M. M. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902780209 · Cited by 84
Asahina, M., Suhara, T., Shinotoh, H., Inoue, O., Suzuki, K. A. O., & Hattori, T. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.155 · Cited by 82
The basal nucleus of Meynert in idiopathic Parkinson's disease
Tagliavini, F., Pilleri, G., Bouras, C., & Constantinidis, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00798.x · Cited by 82
Olfactory Evoked Responses and Identification Tests in Neurological Disease
Hawkes, C. H., & Shephard, B. C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10631.x · Cited by 80
Taylor, J.-P., Rowan, E. N., Lett, D. J., O'Brien, J. T., McKeith, I. G., & Burn, D. J. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.147629 · Cited by 80
Bédard, M., Pillon, B., Dubois, B., Duchesne, N., Masson, H., & Agid, Y. (1999) · Brain and Cognition · doi:10.1006/brcg.1999.1083 · Cited by 78
Dementia in Parkinson's disease
Korczyn, A. D. (2001) · Journal of Neurology · doi:10.1007/pl00022916 · Cited by 68
Cholinergic innervation of the human cerebellum
Lacalle, S. D., Hersh, L. B., & Saper, C. B. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903280304 · Cited by 57
Are dementia and depression in Parkinson's disease related?
LIEBERMAN, A. N. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.022 · Cited by 55
Decrease of Nicotinic Receptors in the Nigrostriatal System in Parkinson's Disease
Kas, A., Bottlaender, M., Gallezot, J., Vidailhet, M., Villafane, G., Grégoire, M., Coulon, C., Valette, H., Dollé, F., Ribeiro, M., et al. (2009) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2009.74 · Cited by 53
Cholinergic vesicular transporters in progressive supranuclear palsy
Suzuki, M., Desmond, T. J., Albin, R. L., & Frey, K. A. (2002) · Neurology · doi:10.1212/wnl.58.7.1013 · Cited by 52
Self-citationMEDICAL MANAGEMENT OF PARKINSON'S DISEASE
Clarke, C. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.suppl_1.i22 · Cited by 50
Frey, K. A., Ehrenkaufer, R. L., Beaucage, S. L., & Agranoff, B. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-02-00421.1985 · Cited by 45
Alzheimer Disease and the Dementia of Parkinson Disease: Comparative Investigations
Mahler, M. E., & Cummings, J. L. (1990) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199040300-00002 · Cited by 41
Acetylcholinesterase-rich pyramidal neurons in alzheimer's disease
Heckers, S., Geula, C., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90072-6 · Cited by 32
Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men
Stein, J. F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.022 · Cited by 20
Neuroimaging of PD, PSP, CBD and MSA—PET and SPECT studies
Shinotoh, H. (2006) · Journal of Neurology · doi:10.1007/s00415-006-3006-6 · Cited by 12
Bédard, M., Lemay, S., Gagnon, J., Masson, H., & Paquet, F. (1999) · Behavioural Neurology · doi:10.1155/1999/316598 · Cited by 12
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease
Wulff, K., Gatti, S., Wettstein, J. G., & Foster, R. G. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2868 · Cited by 1,055
Functional Neuroanatomy for Posture and Gait Control
Takakusaki, K. (2017) · Journal of Movement Disorders · doi:10.14802/jmd.16062 · Cited by 948
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Glutathione metabolism and Parkinson's disease
Smeyne, M., & Smeyne, R. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.001 · Cited by 435
Levodopa Is a Double‐Edged Sword for Balance and Gait in People With Parkinson's Disease
Curtze, C., Nutt, J. G., Carlson‐Kuhta, P., Mancini, M., & Horak, F. B. (2015) · Movement Disorders · doi:10.1002/mds.26269 · Cited by 404
Metadata
- Authors
- Bohnen, N. I., & Albin, R. L.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 221
- Issue
- 2
- Pages
- 564-573
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2087598124
- Cited by
- 566
- References
- 136
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.